Serial 88239260
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Feb 2023)
What this means for you
This application is over — abandoned 20 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88239260
- Mark type
- Design / logo
- Filed
- 21 Dec 2018
- Published for opposition
- 19 Nov 2019
- Abandoned
- 20 Feb 2023
- Attorney of record
- Christina M. Licursi, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases
- Class 042 — Scientific and technological services: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases
Owner
- AI Therapeutics, Inc., Guilford, CT, US
- AI Therapeutics, Inc., Guilford, CT, US
Prosecution history
- 21 Feb 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Feb 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 05 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2022 — SOU EXTENSION 5 GRANTED
- 14 Jul 2022 — SOU EXTENSION 5 FILED
- 01 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jul 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2022 — SOU EXTENSION 4 GRANTED
- 13 Jan 2022 — SOU EXTENSION 4 FILED
- 13 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2021 — SOU EXTENSION 3 GRANTED
- 14 Jul 2021 — SOU EXTENSION 3 FILED
- 14 Jul 2021 — SOU TEAS EXTENSION RECEIVED